Round 2 in Boehringer's US reorganization will claim another 244 jobs, including small molecule group
Boehringer Ingelheim is once again taking out its budget ax and hacking away jobs. Five months after the company told me that it was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.